GSK plc Other Income Expense From Subsidiaries Jointly Controlled Entities And Associates
GSK plc (GLAXF) reported Other Income Expense From Subsidiaries Jointly Controlled Entities And Associates of -GBP 36.00 million for the 12-month period ending 2021-12-31, per its 20-F filed 2022-03-08.
Discontinued › Other Income
ifrs-full:OtherIncomeExpenseFromSubsidiariesJointlyControlledEntitiesAndAssociates · last filed 2022-03-08
| Period end | Other Income Expense From Subsidiaries Jointly Controlled Entities And Associates 12 month |
|---|---|
| 2021-12-31 | -36.00M GBP 20-F · filed 2022-03-08 |
| 2020-12-31 | 0.00 GBP 20-F · filed 2021-03-12 |
| 2019-12-31 | 0.00 GBP 20-F · filed 2021-03-12 |
| 2018-12-31 | 3.00M GBP 20-F · filed 2021-03-12 |
| 2017-12-31 | 94.00M GBP 20-F · filed 2020-03-06 |